Skip to main content
Premium Trial:

Request an Annual Quote

Illumina to Pocket Additional $13.4M as Underwriters Exercise Stock Options

NEW YORK, May 25 (GenomeWeb News) - Illumina yesterday said it stands to pocket an additional $13.4 million after the underwriters for its public stock offering exercised their option to buy a maximum of 525,000 additional shares for $25.50 apiece.

The company said that a total of 4.025 million shares were sold in the stock offering for a net gain of $96.2 million. As GenomeWeb News reported last week, Illumina expected to pocket net proceeds of about $83.6 million from the sale.

Goldman, Sachs & Co. and Merrill Lynch & Co. performed joint bookrunning and acted as co-lead managers of the offering, while Cowen and Company and Robert W. Baird & Co. acted only as co-lead managers.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.